The growth rate of the manufacturing industry accelerated in May. How is the performance of pharmaceutical equipment in sub-sectors?

[ Market Analysis of Chemical Machinery and Equipment Network ] On June 16, the National Bureau of Statistics released the operation of the national economy in May 2021
.
Data show that in May, the added value of industrial enterprises above designated size increased by 8.
8% year-on-year, down 1 percentage point from the previous month
.
This is mainly due to the increase in the base in the same period in 2020, but in terms of the growth rate, it remains basically stable
.
It is worth mentioning that the added value of high-tech manufacturing in May maintained double-digit growth, up 17.
5% year-on-year, significantly faster than the growth rate of all industries
.

 

In addition, from January to May, the national fixed asset investment (excluding farmers) was 19,391.
7 billion yuan, a year-on-year increase of 15.
4%, and an average growth of 4.
2% in the two years; a month-on-month increase of 0.
17% in May
.
Among them, the investment in the manufacturing industry from January to May increased by 20.
4% year-on-year, and the two-year average growth rate changed from a decline from January to April to an increase of 0.
6%
.

 

　　Combining the above data, it can be seen that the domestic manufacturing industry has maintained a growth trend in terms of added value and fixed asset investment.
The market has sufficient vitality and development expectations are improving
.

 

Taking pharmaceutical equipment　　in the manufacturing sub-sector as an example, due to the impact of the epidemic in 2020, the delivery tasks of many pharmaceutical machine companies in the first quarter of 2020 have been hindered, the current sales revenue has dropped significantly, and the current net profit has dropped significantly
.
However, since the second quarter, the production of the pharmaceutical equipment industry has recovered steadily, the number of orders has increased, and the profits of industry enterprises have also maintained rapid growth
.
Judging from the 2020 annual report data disclosed by companies in the pharmaceutical equipment industry, the performance of most listed pharmaceutical machine companies in 2020 is mainly “prosperous”, among which domestic pharmaceutical machine giants represented by Chutian Technology and Tofflon The company's net profit in 2020 increased by 207.
62% and 231.
13% year-on-year respectively, and the net profit has doubled
.

 

　　Thanks to the high profit growth of pharmaceutical machine companies, the growth rate of fixed asset investment in the industry is also accelerating
.
According to the National Bureau of Statistics, from January to December 2020, the national fixed asset investment (excluding rural households) was 51,890.
7 billion yuan, an increase of 2.
9% over the previous year, and the growth rate was 0.
3 percentage points higher than that from January to November
.
Among them, the pharmaceutical manufacturing industry grew rapidly, and the investment increased by 28.
4% over the previous year
.

 

　　In the first quarter of this year, domestic manufacturing investment rebounded, and the growth rate of investment in the pharmaceutical industry further accelerated
.
Data show that the fixed asset investment in the pharmaceutical manufacturing industry from January to April increased by 33.
1% year-on-year
.
Based on the improvement in global demand and the increase in the share of Chinese pharmaceutical manufacturing enterprises, it is expected that China's pharmaceutical manufacturing industry is expected to usher in a new round of fixed asset investment, driving the accelerated development of China's pharmaceutical equipment industry
.
A research report released by Southwest Securities not long ago mentioned that pharmaceutical companies have begun a new round of fixed asset investment, and the growth of the pharmaceutical machinery industry has accelerated, with a year-on-year growth rate of more than 15%
.

 

　　In general, the pharmaceutical equipment industry is ushering in a new growth period.
Both the growth rate of fixed asset investment and corporate profits have improved, and the trend is improving
.
However, the industry also emphasized that the current situation is still severe, and the prices of some bulk commodities such as steel have continued to rise since 2021.
The cost of these raw materials has risen, or the pressure of cost control of drug delivery machine manufacturing enterprises
.
In this context, pharmaceutical machine companies also need to actively respond to control costs and increase profits by continuously increasing the added value of products and accelerating digital transformation
.
It is reported that Canaan Technology replied on the investor interaction platform in May that the price increase of raw materials will have a certain impact on the company, and the company will follow-up through the overall project and the high added value of high-end products and new technologies, and through cooperation with customers.
Friendly negotiation will reduce the impact
.

 

　　Original title: The growth rate of the manufacturing industry accelerated in May.
How is the performance of pharmaceutical equipment in sub-sectors?